Richard Fagan
Director of BioPharm @ UCLB
London, United Kingdom
Richard Fagan is a startup investor at UCLB in London. Rick is a cell and molecular biologist by training, gaining his PhD at McGill University, Canada. This was followed by a postdoctorate at the Imperial Cancer Research Fund, London, and then the National Institute for Medical Research.He left to join AstraZeneca as a team leader in the Department of Target Discovery, then worked forSanofiAventis as a Senior Team leader. In 2001 he left SanofiAventis and joined Impharmatica as Associate Director Target Discovery and worked very closely with the business development team.In 2006 he joined UCLB as Assistant Director BioPharm, becoming Director in 2007.
Last updated:
For AI agents: llms.txt
About UCLB
UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including UniversityCollege Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.
UCLB Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Richard Fagan
Director of BioPharm
|
|||
Anne Lane
Interim Managing Director
|
|||
Marina Santilli
Associate Director (Physical Sciences & Engineering)
|
|||
Simon Goldman
Investment Director
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
